Related to Oxford Nanopore to Pocket £31.4M to Advance Single-Molecule Detection Technology

• Medicinal Genomics Sequences the Genome of Cannabis Sativa and Cannabis Indica
  
• NHGRI Gives $1,000 Genome Project a $14M Shot in the Arm
  
• Complete Genomics to Earn $8M for Sequencing 500 Pediatric Cancer Cases for SAIC-Fredrick
  
• Genomics Departments at Yale and Erasmus Universities Adopt Caliper's Sciclone NGS Workstation
  
• Scientists Complete Genome Sequencing and Analysis of 17 Laboratory Mouse Strains
  
• PacBio Taps Cycle Computing for Next-Gen Sequencing Support on the Cloud
  
• Verinata Enters Supply Agreement with Illumina for Sequencing Instruments
  
• Eurofins and Integrated Genomics Offer Microbial, Fungal, and Algal Sequencing and Analysis
  
• Roche Acquires License to Nanopore Technology with Sights on $1,000 Whole Genome Sequencing
  
• DNAnexus Raises $15M and Seals Cloud Storage Deal with Google to Host New SRA Database Repository
  
• QuantuMDx Licenses Nanosys’ Nanostructures for Use in Handheld Diagnostic Platform
  
• BGI and The Children's Hospital of Philadelphia Set Up Genome Center to Target Pediatric Diseases
  
• New Method for Counting RNA, DNA Molecules Developed
  
• Roswell Park Cancer Institute Gets $5.1M for Sequencing Effort in New York
  
• British Columbia Cancer Agency Added to Illumina Genome Network
  
• GenomeQuest Awards $120K in Grants to Support NGS-Based Diagnostics
  
• Poll Results Point to Personal Sequencing Platforms Entering the Clinic This Year
  
• Roche Outlines $5.7B Bid to Buy Illumina for $44.5 Per Share in Cash
  
• Illumina Institutes Poison Pill to Ward Off Roche’s $5.7B Purchase Proposal
  
• Illumina Shuns Roche’s $5.7 Bid, While Roche Prepares for the Long Haul